Executive Summary
PetVivo Holdings Inc reported a narrow top-line in QQ1 2025 with revenue of $123.8 thousand and a robust gross margin of 89.5%, reflecting a favorable cost of revenue profile. The quarter was dominated by operating losses driven by aggressive spending in research and development and selling, general, and administrative activities, resulting in an EBITDA of -$2.01 million and net income of -$2.05 million. The company continues to burn cash, with operating cash flow of -$1.53 million and free cash flow of -$1.55 million, despite a modest net inflow from financing activities of $1.47 million and a small sequential cash outflow of $74.99 thousand for the period. The balance sheet shows a fragile liquidity position (0.81x current ratio; cash and equivalents of $12.4k; total debt of $1.17 million) and elevated leverage (debt-to-capitalization around 0.58). Management commentary is not available in the provided data, limiting the ability to gauge near-term guidance or strategic color. The combination of a high gross margin on a negligible revenue base and outsized operating expenditure indicates substantial runway risk absent external financing, licensing deals, or material revenue from Kush uptake and pipeline devices. Investors should weigh the potential upside from product commercialization against the pronounced burn and liquidity constraints.
Key Performance Indicators
QoQ: -50.85% | YoY:217.23%
Key Insights
Revenue: $123,751; YoY +5.6%, QoQ +156.39%
Gross Profit: $110,757; Gross Margin 89.50%; YoY +217.23%, QoQ -50.85%
Operating Income: -$2,044,432; Margin -16.52%; YoY +29.35%, QoQ +22.85%
Net Income: -$2,047,063; Net Margin -16.54%; YoY +29.25%, QoQ +22.77%
EPS (diluted): -$0.11; YoY +56.00%, QoQ +42.11%
EBITDA: -$2,010,935; EBITDA Margin -16.25%
Cash Flow and Liquidity: Net cash from operating activities -$1,530,469; Free cash flow -$1,545,647; Cash at end of period $12,414; Net change in cash -$...
Financial Highlights
Revenue: $123,751; YoY +5.6%, QoQ +156.39%
Gross Profit: $110,757; Gross Margin 89.50%; YoY +217.23%, QoQ -50.85%
Operating Income: -$2,044,432; Margin -16.52%; YoY +29.35%, QoQ +22.85%
Net Income: -$2,047,063; Net Margin -16.54%; YoY +29.25%, QoQ +22.77%
EPS (diluted): -$0.11; YoY +56.00%, QoQ +42.11%
EBITDA: -$2,010,935; EBITDA Margin -16.25%
Cash Flow and Liquidity: Net cash from operating activities -$1,530,469; Free cash flow -$1,545,647; Cash at end of period $12,414; Net change in cash -$74,989
Balance Sheet Health: Total assets $2.889B? Note: The reported scale shows $2,888,930 (in thousands in the dataset); Cash & equivalents $12,414; Total liabilities $2,059,427; Total stockholders’ equity $829,503; Net debt $1,154,275; Current ratio 0.807; Quick ratio 0.455
Capital Structure: Long-term debt $968,246; Short-term debt $198,443; Total debt $1,166,689; Leverage metrics indicate significant debt relative to cash resources.
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Revenue |
123.75K |
5.60% |
156.39% |
| Gross Profit |
110.76K |
217.23% |
-50.85% |
| Operating Income |
-2.04M |
29.35% |
22.85% |
| Net Income |
-2.05M |
29.25% |
22.77% |
| EPS |
-0.11 |
56.00% |
42.11% |
Key Financial Ratios
operatingProfitMargin
-1652%
Management Commentary
No earnings call transcript was provided in the data. Unable to extract management quotes or thematic highlights from QQ1 2025 earnings call. Please supply the transcript or management remarks to augment this section with direct quotes and thematic analysis (strategy, operations, market conditions).
Forward Guidance
No formal forward guidance is present in the supplied data. In absence of explicit targets, execution hinges on: (1) Kush commercialization progress and licensing income from pipeline devices, (2) cost containment to improve unit economics, and (3) potential capital raises or financing terms to bridge liquidity gaps. Investors should monitor quarterly cadence of Kush adoption, licensing revenue progress, pipeline advancement, and any capital-raising actions that would materially impact dilution or debt service capability.